Drug Pipeline

Lazertinib Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
13
Active Studies
4
Recruiting
3
Phase 3
4
Top Sponsors
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-03 NCT05663866
Premedication to Reduce Amivantamab Associated Infusion Related Reactions		 date change Completion pushed: 2026-07-30 -> 2027-03-31
New Trial Filings, Last 30 Days
First PostedTrialPhaseStatus
2026-05-14 NCT07586202 A Study of Neoadjuvant Amivantamab With Either Lazertinib or Chemotherapy in Participants… Phase 2 Not Yet Recruiting
Active Studies by Phase
Phase 3
3
Phase 2
8
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT04487080 A Study of Amivantamab and Lazertinib Combination Therapy Versus Osimertinib in Locally… Carcinoma, Non-Small-Cell Lung Active, Not Recruiting
NCT04988295 A Study of Amivantamab and Lazertinib in Combination With Platinum-Based Chemotherapy… Carcinoma, Non-Small-Cell Lung Active, Not Recruiting
NCT05388669 A Study of Lazertinib With Subcutaneous Amivantamab Compared With Intravenous Amivantamab… Advanced or Metastatic Non-small Cell Lung Cancer Active, Not Recruiting
Phase 2
NCT06268210 Neoadjuvant Lazertinib With or Without Chemotherapy for Patients With EGFR-mutated… Non-small Cell Lung Cancer Recruiting
NCT06106802 Lazertinib & Tepotinib for EGFR Mutant NSCLC in MET Overexpressed or Amplified Who… Non-Small Cell Lung Cancer Metastatic Recruiting
NCT05498428 A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including… Carcinoma, Non-small-Cell Lung Recruiting
NCT06667076 A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With… Carcinoma, Non-Small-Cell Lung Recruiting
NCT05601973 Amivantamab, Lazertinib and Bevacizumab in Patients With EGFR-mutant Advanced Non-small… Non Small Cell Lung Cancer Active, Not Recruiting
NCT06120140 Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor… Carcinoma, Non-Small-Cell Lung Active, Not Recruiting
NCT05663866 Premedication to Reduce Amivantamab Associated Infusion Related Reactions Carcinoma, Non-Small-Cell Lung Active, Not Recruiting
NCT07586202 A Study of Neoadjuvant Amivantamab With Either Lazertinib or Chemotherapy in Participants… Carcinoma, Non-Small-Cell Lung Not Yet Recruiting
Phase 1
NCT04077463 A Study of Lazertinib as Monotherapy or in Combination With Amivantamab in Participants… Carcinoma, Non-Small-Cell Lung Active, Not Recruiting
NCT02609776 Study of Amivantamab, a Human Bispecific EGFR and cMet Antibody, in Participants With… Non-Small-Cell Lung Cancer Active, Not Recruiting
Sponsors Running Lazertinib Trials
Janssen Research & Development, LLC (10) ETOP IBCSG Partners Foundation (1) Samsung Medical Center (1) Yonsei University (1)
Disease Areas
Non-Small Cell Lung Cancer (NSCLC) (13) Lung Cancer (5)
Get alerts when Lazertinib trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free